Quick summary

Frankincense (Boswellia sacra) is a resin derived from the Boswellia species, particularly B. sacra. It has been traditionally valued for its aromatic qualities and potential medicinal properties, notably anti-inflammatory effects. Contemporary research has begun to investigate its chemical constituents, biological activities, and possible therapeutic roles in several health conditions. Clinical studies indicate some pain relief and functional improvements in lumbar disc herniation when frankincense is used as part of polyherbal formulations. However, evidence specifically for B. sacra alone remains limited, and larger well-designed clinical trials are needed.

What is it

Frankincense is a fragrant resin obtained from the bark of trees in the Boswellia genus, primarily Boswellia sacra. It has been used for centuries in religious ceremonies, perfumery, and traditional medicine, especially in regions of the Arabian Peninsula and parts of Africa. The resin contains various bioactive compounds, including boswellic acids, which are believed to contribute to its biological effects.

Traditional uses

  • Aromatherapy and incense in spiritual and religious practices.
  • Traditional medicines have applied frankincense for inflammatory conditions, joint pain, and respiratory illnesses.
  • Used historically as an anti-inflammatory and for wound healing.

Active compounds

Key bioactive components of frankincense include boswellic acids, which are pentacyclic triterpenes. These compounds are thought to modulate inflammatory pathways such as NF-κB, 5-lipoxygenase (5-LOX), and cyclooxygenase-2 (COX-2). Other constituents include essential oils, diterpenes, and polysaccharides.

Potential benefits with evidence levels

  • Pain management in lumbar disc herniation: A moderate level of evidence (1 randomized controlled trial with 100 participants) found that a Chinese herbal gel plaster containing frankincense as part of a multi-herb formula combined with manipulation showed greater pain reduction and functional improvement compared to placebo.
  • Anti-inflammatory potential: Boswellic acids demonstrate anti-inflammatory effects in preclinical studies and some limited clinical support by modulating multiple inflammatory pathways.
  • Osteoarthritis symptom relief: Moderate evidence from systematic reviews and meta-analyses of 7 RCTs (545 patients) suggests Boswellia extracts may reduce pain, stiffness, and improve joint function.
  • Potential adjunct in cancer chemotherapy: Low to moderate evidence from systematic reviews of Chinese polyherbal formulas containing frankincense indicates possible efficacy and safety as adjuvant therapy in gastric cancer, though effects specific to frankincense alone are unclear.
  • Neuroprotective effects in animal models: Preclinical animal studies show neuroprotection against electromagnetic radiation-induced neuronal damage, with frankincense attenuating neurodegenerative changes in the hippocampus and cerebellum.
  • Potential immunomodulatory effects: Traditional use and limited pharmacological research suggest immunomodulatory activities affecting cytokines and immune cell functions; clinical evidence is sparse.

Side effects

Frankincense and Boswellia extracts generally have a favorable safety profile in clinical studies, with no serious adverse events reported. The most commonly observed mild adverse effect is gastrointestinal discomfort. Effects are usually mild and transient.

Drug interactions

There is no direct evidence or detailed study data on specific drug interactions with Boswellia sacra. However, caution is advised due to possible theoretical interactions with anti-inflammatory or anticoagulant medications based on the pharmacology of boswellic acids.

Who should avoid it

Due to limited clinical data, specific contraindications for Boswellia sacra are not well established. Use should be cautious in individuals with bleeding disorders or those taking blood-thinning agents until more safety data are available. Limited safety information is available for pregnant or breastfeeding women; thus, it is generally recommended to avoid frankincense during pregnancy and lactation unless supervised by a healthcare provider.

Evidence limitations

  • Most clinical evidence involves Boswellia extracts used within polyherbal formulations rather than frankincense from Boswellia sacra alone, limiting the ability to attribute effects specifically.
  • Many studies have small sample sizes, short treatment durations, and some methodological limitations.
  • Preclinical studies outnumber high-quality large-scale randomized controlled trials.
  • Data are limited on pharmacokinetics, optimal dosing, long-term safety, and potential drug interactions.
  • Safety evidence during pregnancy and breastfeeding is scarce.
  • Variability in extract composition and processing methods affects reproducibility of results.

References

Last reviewed

June 2024

Informational disclaimer: This page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new treatment, especially if you have existing health conditions or are taking other medications.